CDDEP relies on grants and the generosity of donors to support data collection and ensure that ResistanceMap stays up-to-date with the latest antimicrobial use and resistance data. Please help us ensure the continued operation of ResistanceMap through a donation today >>
Data includes aggregated resistance rates for isolates (includes intermediate resistance) from blood and cerebrospinal fluid (i.e., invasive) from inpatients of all ages. Because of differences in scope of collections and testing methods, caution should be exercised in comparing across countries. For more details see methodology
Country boundaries/designations do not represent CDDEP opinion concerning the legal status of any country, territory, city, or area of its authorities, or concerning the delimitation of its frontiers or boundaries.
Cephalosporins (3rd gen)
Australian Group on Antimicrobial Resistance (AGAR)
European Antimicrobial Resistance Surveillance Network (EARS-Net)
Canadian Antimicrobial Resistance Alliance (CARA)
A private tertiary-care hospital, Kenya
Public Health Surveillance, New Zealand
South African Society for Clinical Microbiology
National Antimicrobial Resistance Surveillance Center, Thailand (NARST)
The Surveillance Network (TSN)
Vietnam Resistance Project (VINARES)
Central Asian and Eastern European Surveillance of Antimicrobial Resistance
To learn how this data was collected, see our methodology overview.
Boundaries and names shown and the designation used on these maps do not imply the expression of any opinion whatsoever on the part of CDDEP concerning the legal status of any country, territory, city or area of its authorities, or concerning the delimitation of its frontiers or boundaries.